EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND CHRONIC KIDNEY DISEASE

K. Todorov, I. Dudrenova

TRAKIA JOURNAL OF SCIENCES · 04.06.2026 · 24 (1) · 8

DOI: 10.15547/tjs.2026.01.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TRAKIA JOURNAL OF SCIENCES, online erschienen am 04.06.2026. Verfasst von K. Todorov und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nomenclature of non-alcoholic fatty liver disease (NAFLD) has recently undergone substantial revision to better reflect its underlying pathophysiological link with metabolic dysfunction. In 2023, the designation metabolic dysfunction-associated steatotic liver disease (MASLD) was formally adopted, superseding NAFLD. The updated definition incorporates the requirement for at least one cardiometabolic risk factor, thereby refining diagnostic accuracy and emphasizing the systemic nature of the condition. Emerging evidence consistently demonstrates a strong association between MASLD and chronic kidney disease (CKD). This interrelation appears to be mediated through shared pathogenic mechanisms, including insulin resistance, chronic subclinical inflammation, endothelial dysfunction, and activation of the renin–angiotensin–aldosterone system. Notably, individuals with MASLD exhibit an elevated risk of developing CKD compared with those without metabolic hepatic steatosis, independent of conventional risk factors.

Zitieren

APA

Todorov, K., & Dudrenova, I. (2026). METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND CHRONIC KIDNEY DISEASE. TRAKIA JOURNAL OF SCIENCES, 24(1), 8. https://doi.org/10.15547/tjs.2026.01.011

Vancouver

Todorov K, Dudrenova I. METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND CHRONIC KIDNEY DISEASE. TRAKIA JOURNAL OF SCIENCES. 2026;24(1):8. doi:10.15547/tjs.2026.01.011

BibTeX
@article{Todorov2026,
  author = {Todorov, K. and Dudrenova, I.},
  title = {METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND CHRONIC KIDNEY DISEASE},
  journal = {TRAKIA JOURNAL OF SCIENCES},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {8},
  doi = {10.15547/tjs.2026.01.011}
}
Kostenlos starten →